Hanger, Inc. provides orthotic and prosthetic (O&P) services; and distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to patients and businesses in acute, post-acute, and clinic settings in the United States. It operates through two segments, Patient Care and Products & Services. The Patient Care segment owns and operates Hanger clinic, which specializes in the design, fabrication, and delivery of custom O&P devices through patient care clinics and satellite locations; and provides payor network contracting services to other O&P providers. The Products & Services segment procures and distributes O&P parts, componentry, and devices to independent O&P providers; and develops specialized rehabilitation technologies and provides evidence-based clinical programs for post-acute rehabilitation to patients at approximately 4,000 skilled nursing and post-acute providers. This segment also manufactures and sells therapeutic footwear for diabetic patients in the podiatric market. As of May 14, 2018, the company owned and operated approximately 800 patient care clinics in the United States. The company was formerly known as Hanger Orthopedic Group, Inc. and changed its name to Hanger, Inc. in June 2012. Hanger, Inc. was founded in 1861 and is headquartered in Austin, Texas.
Industry, Sector and Symbol
Industry Specialty outpatient clinics, not elsewhere classified
Sub-IndustryHealth Care Facilities
SectorMedical
Phone512-777-3800
Debt
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Price / Cash FlowN/A
Price / BookN/A
Profitability
Net IncomeN/A
Net MarginsN/A
Return on AssetsN/A
Miscellaneous
Employees4,600
OptionableOptionable
Hanger (OTCMKTS:HNGR) Frequently Asked Questions
What is Hanger's stock symbol?
Hanger trades on the OTCMKTS under the ticker symbol "HNGR."
How were Hanger's earnings last quarter?
Hanger Inc (OTCMKTS:HNGR) announced its quarterly earnings results on Thursday, November, 8th. The healthcare company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.21 by $0.01. The healthcare company earned $262.95 million during the quarter, compared to analysts' expectations of $260.07 million. View Hanger's Earnings History.
When is Hanger's next earnings date?
What price target have analysts set for HNGR?
1 Wall Street analysts have issued 12 month price targets for Hanger's stock. Their predictions range from $17.00 to $17.00. On average, they expect Hanger's stock price to reach $17.00 in the next twelve months. This suggests that the stock has a possible downside of 16.6%. View Analyst Price Targets for Hanger.
What is the consensus analysts' recommendation for Hanger?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hanger in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Hanger.
Has Hanger been receiving favorable news coverage?
News stories about HNGR stock have trended positive on Thursday, according to InfoTrie. The research firm ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Hanger earned a coverage optimism score of 2.6 on InfoTrie's scale. They also assigned news articles about the healthcare company a news buzz of 8.0 out of 10, meaning that recent media coverage is very likely to have an effect on the stock's share price in the next several days.
Who are some of Hanger's key competitors?
Some companies that are related to Hanger include 22nd Century Group (XXII), 3D Signatures (DXD), 4d Pharma (DDDD), Abattis Bioceuticals (ATTBF), Abaxis (ABAX), Abcam (ABC), ABcann Global (ABCN), ABLYNX NV/ADR (ABLX), ABZENA/PAR VTG FPD 0.002 (ABZA), Acasti Pharma (ACST), Acerus Pharmaceuticals (ASP), Acrux (ACR), Actinium Pharmaceuticals (ATNM), Actinogen Medical (ACW) and Activecare (ACAR).
Who are Hanger's key executives?
Hanger's management team includes the folowing people:
- Mr. Vinit K. Asar, CEO, Pres & Director (Age 52)
- Mr. Thomas E. Kiraly, CFO & Exec. VP (Age 58)
- Mr. Thomas E. Hartman, Sr. VP, Gen. Counsel & Sec. (Age 55)
- Mr. Samuel M. Liang, Pres of Hanger Clinic (Age 55)
- Ms. Gabrielle B. Adams, VP & Chief Accounting Officer (Age 49)
Who are Hanger's major shareholders?
Hanger's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Virtu Financial LLC (0.03%) and CenterStar Asset Management LLC (0.00%). View Institutional Ownership Trends for Hanger.
Which major investors are selling Hanger stock?
Which major investors are buying Hanger stock?
How do I buy shares of Hanger?
Shares of HNGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Hanger's stock price today?
One share of HNGR stock can currently be purchased for approximately $20.38.
What is Hanger's official website?
How can I contact Hanger?
Hanger's mailing address is 10910 DOMAIN DRIVE SUITE 300, AUSTIN TX, 78758. The healthcare company can be reached via phone at 512-777-3800 or via email at [email protected]
MarketBeat Community Rating for Hanger (OTCMKTS HNGR)
MarketBeat's community ratings are surveys of what our community members think about Hanger and other stocks. Vote "Outperform" if you believe HNGR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HNGR will underperform the S&P 500 over the long term. You may vote once every thirty days.
